Mironid Funding: $44M Raised, Series A (2023)

Mironid funding overview

Mironid is based in Glasgow, United Kingdom. Mironid has raised $44M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2023. The round record for Mironid runs through 2023; nothing later has been disclosed. Investors on record include Roche Venture Fund, Epidarex Capital, Sofinnova Partners, BioGeneration Ventures, University of Strathclyde, Scottish Enterprise and 1 others. 7 distinct backers are named across the disclosed rounds.

Mironid at a glance

Total raised: $44M
Latest round: Series A
Latest round date: September 2023
Headquarters: Glasgow, United Kingdom
Notable investors: Roche Venture Fund, Epidarex Capital, Sofinnova Partners, BioGeneration Ventures, University of Strathclyde, Scottish Enterprise, European Investment Fund

Frequently asked about Mironid funding

How much has Mironid raised?: Mironid has raised $44M in total disclosed funding across the rounds on record.
Who has invested in Mironid?: Roche Venture Fund, Epidarex Capital, Sofinnova Partners, BioGeneration Ventures, University of Strathclyde, Scottish Enterprise are named among the investors backing Mironid.
What was the latest Mironid funding round?: The most recent disclosed round is a Series A, announced in September 2023.
Where is Mironid based?: Mironid is based in Glasgow, United Kingdom.
When did Mironid last raise?: The last disclosed Mironid round closed in September 2023 at Series A.

Mironid totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Glasgow below to benchmark round size and investor mix.

Mironid Funding: $44M Raised, Series A (2023)

Mironid funding overview

Mironid at a glance

Frequently asked about Mironid funding

Companies related to Mironid (24)

Browse related funding lists (6)